A large study in older adults with type 2 diabetes finds that GLP-1 receptor agonists are associated with a modestly ...

Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose ...

The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...

Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists. (HealthDay News) — Many Medicaid ...

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the ... Novo Nordisk’s big-selling Ozempic/Wegovy (semaglutide), used to treat type 2 diabetes ...

The EMA’s safety committee has said that, after a review of available data, it has found no evidence that GLP-1 agonist drugs ... for Wegovy that mentions that semaglutide has been shown to ...

You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...